-transparent.png){kind=logo}
Over the past decade, antiproliferative effects of somatostatin and analogs have been reported in many somatostatin receptor-positive normal and tumor cell types. Regarding the molecular mechanisms involved, somatostatin or analogs mediate their action through both indirect and direct effects. Somatostatin acts through five somatostatin receptors (SSTR1-5) which are variably expressed in normal and tumor cells. These receptors regulate a variety of signal transduction pathways including inhibition of adenylate cyclase, regulation of ion channels, regulation of serine/threonine and tyrosine kinases and phosphatases. This review focuses on recent advances in biological mechanisms involved in the antineoplastic activity of somatostatin and analogs.
C Bousquet, and
E Puente, and
L Buscail, and
N Vaysse, and
C Susini
June 2010,
World journal of gastroenterology,
C Bousquet, and
E Puente, and
L Buscail, and
N Vaysse, and
C Susini
January 2006,
Pituitary,
C Bousquet, and
E Puente, and
L Buscail, and
N Vaysse, and
C Susini
May 2009,
F1000 medicine reports,
C Bousquet, and
E Puente, and
L Buscail, and
N Vaysse, and
C Susini
January 2021,
Neuroendocrinology,
C Bousquet, and
E Puente, and
L Buscail, and
N Vaysse, and
C Susini
January 2016,
Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti,
C Bousquet, and
E Puente, and
L Buscail, and
N Vaysse, and
C Susini
January 2009,
Acta gastro-enterologica Belgica,
C Bousquet, and
E Puente, and
L Buscail, and
N Vaysse, and
C Susini
July 2017,
Oncotarget,
C Bousquet, and
E Puente, and
L Buscail, and
N Vaysse, and
C Susini
January 2024,
Therapeutic advances in medical oncology,
C Bousquet, and
E Puente, and
L Buscail, and
N Vaysse, and
C Susini
July 1977,
FEBS letters,
C Bousquet, and
E Puente, and
L Buscail, and
N Vaysse, and
C Susini
October 2006,
Polskie Archiwum Medycyny Wewnetrznej,
